我要投票 云河在医疗器械行业中的票数:577
· 外 推 电 报 ·
2026-01-09 05:57:12 星期五

【云河是哪个国家的品牌?】

云河是什么牌子?「云河」是 云南云河药业股份有限公司 旗下著名品牌。该品牌发源于云南省红河哈尼族彝族自治州,在1958年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力云河品牌出海!将品牌入驻外推网,定制云河品牌推广信息,可以显著提高云河产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

云南云河药业股份有限公司,始于1958年,云南省著名商标,云南省名牌产品,知名伤药品牌,集西药/中成药开发、制造、销售为一体的高新技术企业


云南云河药业股份有限公司(简称云河药业)前身是国有的云南省个旧市制药厂,始建于1958年,坐落在个旧市云河大道1号,2001年末按现代企业制度改制为非公有制企业。

云河药业现占地约56亩,建筑面积约55987㎡,注册资本为8730万元,总资产为39550万元,净资产为15958万元。云河药业下属有2家全资子公司,共拥有员工300余人,拥有覆盖全国的市场营销网络和经销商队伍;拥有通过了GMP标准认证的大、小容量注射剂、胶囊剂、片剂、散剂、颗粒剂、酊剂、溶液剂、糖浆剂、合剂、原料药等11个剂型共74个品种规格的药品现代化生产线,其中22个品种列入国家基本药物目录,另有7个品种列入国家基本药物目录云南省补充目录;拥有13个国家发明专利和4个外观设计专利证书。云河药业依托云南省得天独厚的天然药物宝库和东南亚地道天然药材资源,挖掘中华医学精华的传统医药、民族药秘方,多年来先后研制出具有自主知识产权的、畅销国内外的“虎力散胶囊”、“龙血竭胶囊”、“香果健消片”等国家中药保护的特色品种和专利新药“复方龙血竭胶囊”。

主要产品已在美国、俄罗斯、新加坡成功注册并启动销售。目前,公司已进入高速发展阶段。


英文翻译:Yunnan Yunhe Pharmaceutical Co., Ltd. was founded in 1958. It is a famous trademark of Yunnan Province, famous brand product of Yunnan Province, well-known brand of wound medicine. Yunnan Yunhe Pharmaceutical Co., Ltd. (hereinafter referred to as Yunhe pharmaceutical) is a high-tech enterprise integrating the development, manufacturing and sales of Western Medicine / Chinese patent medicine. Its predecessor is the state-owned Gejiu pharmaceutical factory of Yunnan Province. It was founded in 1958 and is located in Yunhe, Gejiu City At the end of 2001, it was transformed into a non-public enterprise according to the modern enterprise system. Yunhe pharmaceutical now covers an area of about 56 mu, with a building area of about 55987 ㎡, a registered capital of 87.3 million yuan, a total asset of 395.5 million yuan and a net asset of 159.58 million yuan. Yunhe pharmaceutical has two wholly-owned subsidiaries, with more than 300 employees, a nationwide marketing network and a team of distributors. It has 11 pharmaceutical modern production lines with 74 varieties and specifications, including large and small volume injection, capsule, tablet, powder, granule, tincture, solution, syrup, mixture and API, which have passed GMP standard certification, Among them, 22 varieties are listed in the national essential drug catalogue, and 7 varieties are listed in the supplementary catalogue of Yunnan Province; there are 13 national invention patents and 4 design patent certificates. Relying richly endowed by nature's natural resources and natural resources of Southeast Asia, Yunhe pharmaceutical industry has been exploring the traditional medicine and folk medicine secret recipe of Chinese medicine essence. For many years, it has developed a variety of patent medicines and new patents which have independent intellectual property rights and sell well at home and abroad, such as "Huli San capsule", "dragon blood capsule" and "Xiang Guo Jian Xiao tablet" and other national traditional Chinese medicine protection. "Yunhe medicine" is a new product of Yunnan. Medicine "compound dragon blood capsule". The main products have been successfully registered and sold in the United States, Russia and Singapore. At present, the company has entered a high-speed development stage.

本文链接: https://www.waitui.com/brand/b75d89c45.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

宏润建设:股东周美珍计划减持不超0.12%股份

36氪获悉,宏润建设公告,股东周美珍因个人资金需求,计划自公告披露之日起十五个交易日后的三个月内,即2026年1月30日至2026年4月29日,通过集中竞价交易方式减持公司股份不超过150.10万股,占剔除公司回购专用账户股份后总股本的0.12%。减持股份来源:因离婚财产分割、通过非交易过户取得的股份。

2小时前

欧盟反垄断监管机构定于2月10日前就谷歌收购Wiz的交易作出裁决

据欧盟委员会网站公示文件,欧盟反垄断监管机构将于2月10日前裁定,是否批准Alphabet以320亿美元收购网络安全公司Wiz的交易,这也是Alphabet有史以来规模最大的一笔收购。(新浪财经)

2小时前

谱尼测试:股票交易严重异常波动 预计2025年度亏损2亿元-2.5亿元

36氪获悉,谱尼测试公告,公司股票自2025年12月24日至2026年1月8日连续10个交易日内日收盘价格涨幅偏离值累计达到+100%,属于股票交易严重异常波动的情况。公司预计2025年度亏损2亿元到2.5亿元。经核实,公司不存在违反信息公平披露的情形,也无应披露而未披露的重大事项或处于筹划阶段的重大事项。公司提醒广大投资者理性投资,注意投资风险。

2小时前

美股大型科技股盘前涨跌不一,苹果跌超1%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,苹果跌超1%,特斯拉跌0.88%,微软跌0.64%,Meta跌0.43%,奈飞跌0.32%;谷歌涨0.91%,英伟达涨0.31%,亚马逊涨0.23%。

2小时前

热门中概股美股盘前多数下跌,哔哩哔哩涨近3%

36氪获悉,热门中概股美股盘前多数下跌,截至发稿,拼多多、百度、爱奇艺跌超1%,京东跌0.72%,阿里巴巴跌0.48%,理想汽车跌0.35%,哔哩哔哩涨近3%,小鹏汽车涨超1%,蔚来涨0.21%。

2小时前

本页详细列出关于云河的品牌信息,含品牌所属公司介绍,云河所处行业的品牌地位及优势。
咨询